ZERONDA TYLER (Interim CFO) reported 1 transaction at VYNE THERAPEUTICS INC.
Review the transaction codes below to understand the nature of each event.
Filed: 1/4/2022ACC: 0001209191-22-000861
Officer· Interim CFO
Since Jun 2021
-206.00
Net shares
Net seller
$210.12
Total sold
0
Open market trades
0B · 0S
1
Total transactions
206.00 disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−206.00
Price / share
$1.02
Trade value
$210.12
% of position
0.2%
12/31/2021
87.53K→87.33K
Total
Net shares
−206.00
Net value
-$210.12
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 12/31/2021 | F · Tax Withholding | −206.00 | $1.02 | $210.12 | 0.2% | 87.53K | 87.33K |
| Total | −206.00 | -$210.12 | ||||||
Derivative Transactions0
No derivative transactions reported